Crossmark Global Holdings, Inc. Ligand Pharmaceuticals Inc Transaction History

Crossmark Global Holdings, Inc.

  • $5.23 Billion
  • Q2 2024

A detailed history of Crossmark Global Holdings, Inc. transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 7,088 shares of LGND stock, worth $690,158. This represents 0.01% of its overall portfolio holdings.

Number of Shares
7,088
Previous 7,003 1.21%
Holding current value
$690,158
Previous $512,000 16.6%
% of portfolio
0.01%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024
BUY
$68.53 - $87.91 $5,825 - $7,472
85 Added 1.21%
7,088 $597,000
Q1 2024

May 13, 2024
BUY
$68.64 - $89.2 $480,685 - $624,667
7,003 New
7,003 $512,000
Q1 2022

May 11, 2022
SELL
$94.99 - $151.56 $160,343 - $255,833
-1,688 Closed
0 $0
Q4 2021

Jan 10, 2022
BUY
$127.69 - $165.85 $29,368 - $38,145
230 Added 15.78%
1,688 $261,000
Q3 2021

Oct 21, 2021
BUY
$102.33 - $144.73 $149,197 - $211,016
1,458 New
1,458 $203,000
Q2 2021

Jul 21, 2021
SELL
$113.03 - $155.64 $163,441 - $225,055
-1,446 Closed
0 $0
Q1 2021

Apr 15, 2021
BUY
$99.52 - $215.83 $143,905 - $312,090
1,446 New
1,446 $220,000
Q4 2020

Jan 14, 2021
SELL
$80.55 - $106.05 $258,243 - $339,996
-3,206 Closed
0 $0
Q3 2020

Oct 08, 2020
SELL
$89.56 - $126.72 $9,851 - $13,939
-110 Reduced 3.32%
3,206 $306,000
Q2 2020

Aug 14, 2020
BUY
$68.28 - $123.65 $4,779 - $8,655
70 Added 2.16%
3,316 $371,000
Q1 2020

Apr 28, 2020
SELL
$63.37 - $107.88 $3,168 - $5,394
-50 Reduced 1.52%
3,246 $236,000
Q4 2019

Feb 06, 2020
BUY
$96.94 - $113.59 $84,337 - $98,823
870 Added 35.86%
3,296 $344,000
Q3 2019

Oct 09, 2019
SELL
$86.25 - $120.16 $12,937 - $18,024
-150 Reduced 5.82%
2,426 $241,000
Q2 2019

Jul 09, 2019
SELL
$107.38 - $129.34 $30,388 - $36,603
-283 Reduced 9.9%
2,576 $294,000
Q1 2019

May 02, 2019
BUY
$105.93 - $142.47 $2,118 - $2,849
20 Added 0.7%
2,859 $359,000
Q4 2018

Jan 31, 2019
SELL
$128.36 - $272.13 $41,075 - $87,081
-320 Reduced 10.13%
2,839 $385,000
Q3 2018

Nov 08, 2018
SELL
$211.18 - $274.49 $44,136 - $57,368
-209 Reduced 6.21%
3,159 $867,000
Q2 2018

Jul 31, 2018
BUY
$150.77 - $207.98 $24,424 - $33,692
162 Added 5.05%
3,368 $698,000
Q1 2018

Apr 16, 2018
SELL
$138.63 - $182.62 $22,180 - $29,219
-160 Reduced 4.75%
3,206 $530,000
Q4 2017

Feb 05, 2018
BUY
$128.36 - $147.04 $31,191 - $35,730
243 Added 7.78%
3,366 $461,000
Q3 2016

Oct 25, 2017
BUY
N/A
3,123
3,123 $425,000

Others Institutions Holding LGND

# of Institutions
247
Shares Held
17.5M
Call Options Held
61K
Put Options Held
7.8K
View Full List

About LIGAND PHARMACEUTICALS INC

LGND Quotes by TradingView
  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.64B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Crossmark Global Holdings, Inc. Portfolio

Follow Crossmark Global Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email